Cancer Flashcards
Cancer
Defective cellular proliferation
Defective cellular differentiation
- Malignant
less differentiated
Grow rapidly- lost ability to control cell proliferation and differentiation-> disorganised growth and metastasis (invade and infiltrate)
2 categories- solid tumours and hematologic
Genetically altered cell
A cell within a normal population sustains genetic mutation that increases its propensity ti proliferate when it would normally rest.
Hyperplasia
The altered cell and its dependent continue to look normal but they reproduce too much. After years one in a million of these cells suffers another mutation that further loosens controls on cell growth.
Dysplasia
In addition to proliferating excessively these cells mutate which alters cell behaviour.
Metastasis
Cells mutate the ability to Lyse and gain access to circulatory system giving them access to the rest of the body.
Tumour cell characters
- Differentiation anaplasia
- Genetic instability and chromosome abnormality
- Growth
- Growth factor independence
- Lack of cell density inhibition
- Impaired cohesiveness and adhesion
- Anchorage independence
- Faulty cell-cell communication
- Immortality
CANCER CLASSIFICATION - Grade
HISTOLOGY
Grade l: cell differ slightly from normal cells and well differentiated
Grade ll: cells are more abnormal and moderately differentiated
Grade lll: cells are very abnormal and poorly differentiated
Grade lV: cells are immature and undifferentiated
CANCER CLASSIFICATION- Stage
EXTENT OF DISEASE:
Stage 0: cancer in situ
Stage l: tumour limited to the tissue of origin
Stage ll: limited local spread
Stage lll: extensive local and regional spread
Stage lV: metastasis
Genetic and Molecular basis of CANCER
Recognition of genetic factors in cancers has important implications:
identifying individuals who are at particular risk;
BRCA1 and BRAC2 mutation
Present in 33% women under 29 with breast cancer
Present 2% women 70-79 with breast cancer
means for diagnosis,
Leads to the development of therapy
Molecular fingerprint.
Epigenetic factors and micro RNA genes
There are 2 key differences between cancer and most genetic diseases: -
most Cancer, caused by somatic mutations, all other genetic diseases caused by germline mutations.
Each cancer arises from the accumulation of several mutations - “multi-hit” process.
Cell division and its control
p53 acts to activate the transcription of p21 and p27 inhibitors of the cdk/cyclin kinases and therefore work to block the transition of the cell from G1 to S.
Mutations and cancer
Control of cell division is regulated in 2 ways:
- Genes that suppress cell division -Tumour suppressor genes - control abnormal cell proliferation and therefore suppress tumorigenesis e.g. p53, RB1
- Genes that promote cell division (proto-) Oncogenes promotes cell proliferation and differentiation, e.g. growth factors, transmembrane kinase, signal transducers
Knudsons 2 hit hypothesis
Sporadic - takes time to inactivate both copies of the allele
Hereditary - one copy already inactivated so cancer develops much faster.
STAGES OF CANCER DEVELOPMENT
INITIATION-irriversible alteration in the cell’s genetic structure
PROMOTION-second cell mutation
PROGRESSION-increased growth rate, invasiveness, cell proliferation and metastasis
Environmental factors
Diet/lifestyle (eating, breathing, sex, sun, alcohol)
Tobacco
Viruses (HIV, HepB, HPV)
Occupational exposure
ROLE OF IMMUNE SYSTEM
To detect microorganisms and dead cells.
To destroy microorganisms and dead cells.
Tumour-associated antigens make it possible for immune system to detect cancer and destroy it.
If tumour-associated antigens are altered the immune system may fail to detect cancer cells.
Blocking of antigen will prevent recognition by antibodies and therefore no destruction of cancer cells occurs.